（文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：公司人工大血管项目进展如何，有没有可能BD？ 京新药业（002020.SZ）8月15日在投资者互动平台表示，公司人工大血管项目已经进入到临床试验阶 段。后续情况请关注相关公告。 ...

Core Viewpoint - The company, Jingxin Pharmaceutical, has announced that its artificial large blood vessel project has entered the clinical trial phase [1] Group 1 - The artificial large blood vessel project is a significant development for the company, indicating progress in its research and development efforts [1]